Posted by Michael Wonder on 01 Sep 2022
Vabysmo (faricimab injection) receives positive CADTH recommendation for the treatment of neovascular (wet) age-related macular degeneration in adults
1 September 2022 - Provincial jurisdictions will make the final decision on public reimbursement.
Roche Canada is pleased to announce that on 30 August 2022, the CADTH Canadian Drug Expert Committee recommended Vabysmo (faricimab injection) for public reimbursement.
